The text starts here.

Access to Medicines

Our Approach

Advocacy

May 7, 2012

3. Eisai Advocacy work examples (3/3)

  1. 3)Advocacy Work Through Public Events
    Eisai takes appropriate opportunities to explain its views and policy positions at public events. For example:

IFPMA Assembly, Washington DC, US (November 2010)

Eisai was proud to play a leading role in the 2010 IFPMA Assembly, held in Washington, DC in November of that year under the theme “A Shared Commitment to Global Health”
(http://www.ifpma.org/events/assemblies/view/article/25th-ifpma-assembly.html)

As the then IFPMA President, Eisai's CEO Mr Haruo Naito made the welcome remarks at the Assembly, during which he spoke of the importance of partnership between the pharmaceutical industry and others:

“Improving global health is a challenge of such a magnitude that it can only be realistically achieved through the active engagement and cooperation of all key stakeholders, including the pharmaceutical industry. The industry recognizes that it must be a partner in delivering improved healthcare to patients, right across the world, and must work with others to increase access to medicines, particularly in developing countries.”

(http://www.ifpma.org/fileadmin/content/Events/Assemblies/Speech_Assembly _Naito_10Nov2010.pdf)

DNDi Annual Partners' Meeting, Rio de Janeiro, Brazil (December 2011)

Eisai participated in the DNDi (Drugs for Neglected Disease initiative) Annual Partners' Meeting, held on 2 December, 2011 in Rio de Janeiro, Brazil. Eisai's Director for Global Partner Solutions, Dr BT Slingsby, spoke on a panel entitled “Innovation: from patient needs to implementation of new treatments”. Dr Slingsby explained Eisai's belief in the importance of product development partnerships, such as Eisai's collaboration with DNDi on a potential new treatment for Chagas disease.

London Declaration, London, UK (January 2012)

Eisai was one of the thirteen major research and development-based pharmaceutical companies, together with the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the US and UK governments, the World Bank and governments from neglected tropical disease (NTD)-endemic countries, to give its support on 30 January, 2012 to the London Declaration, a coordinated effort to eliminate 10 NTDs by the end of this decade.
(http://www.eisai.com/news/news201206.html)

Related Links